These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 9675547
1. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium. Lorian V, Fernandes F. Drugs Exp Clin Res; 1998; 24(2):73-6. PubMed ID: 9675547 [Abstract] [Full Text] [Related]
2. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Winston DJ, Emmanouilides C, Kroeber A, Hindler J, Bruckner DA, Territo MC, Busuttil RW. Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685 [Abstract] [Full Text] [Related]
3. Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium. Lorian V, Fernandes F. J Antimicrob Chemother; 1997 May; 39 Suppl A():63-6. PubMed ID: 9511065 [Abstract] [Full Text] [Related]
5. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M, Sokolow R, DeBess E, Gilbert L, Benson JA, Hill B, Angulo FJ. N Engl J Med; 2001 Oct 18; 345(16):1155-60. PubMed ID: 11642231 [Abstract] [Full Text] [Related]
8. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus. Kang SL, Rybak MJ. J Antimicrob Chemother; 1997 May 18; 39 Suppl A():33-9. PubMed ID: 9511060 [Abstract] [Full Text] [Related]
9. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. Werner G, Klare I, Spencker FB, Witte W. J Antimicrob Chemother; 2003 Jul 18; 52(1):113-5. PubMed ID: 12805253 [Abstract] [Full Text] [Related]
10. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans. Kieke AL, Borchardt MA, Kieke BA, Spencer SK, Vandermause MF, Smith KE, Jawahir SL, Belongia EA, Marshfield Enterococcal Study Group. J Infect Dis; 2006 Nov 01; 194(9):1200-8. PubMed ID: 17041845 [Abstract] [Full Text] [Related]
11. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium. Hill RL, Smith CT, Seyed-Akhavani M, Casewell MW. J Antimicrob Chemother; 1997 May 01; 39 Suppl A():23-8. PubMed ID: 9511058 [Abstract] [Full Text] [Related]
12. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. Williams JD, Maskell JP, Whiley AC, Sefton AM. J Antimicrob Chemother; 1997 May 01; 39 Suppl A():41-6. PubMed ID: 9511061 [Abstract] [Full Text] [Related]
13. Quinupristin/dalfopristin: a treatment option for vancomycin-resistant Enterococci. Kim MK, Nicolau DP, Nightingale CH, Quintiliani R. Conn Med; 2000 Apr 01; 64(4):209-12. PubMed ID: 10812767 [No Abstract] [Full Text] [Related]
15. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L. Int J Antimicrob Agents; 2004 May 01; 23(5):510-2. PubMed ID: 15120733 [Abstract] [Full Text] [Related]